Intermittent schedules of the oral RAF–MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: a single-centre, open-label, phase 1 dose-escalation and basket dose-expansion study
Titel:
Intermittent schedules of the oral RAF–MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: a single-centre, open-label, phase 1 dose-escalation and basket dose-expansion study
Auteur:
Guo, Christina Chénard-Poirier, Maxime Roda, Desamparados de Miguel, Maria Harris, Samuel J Candilejo, Irene Moreno Sriskandarajah, Priya Xu, Wen Scaranti, Mariana Constantinidou, Anastasia King, Jenny Parmar, Mona Turner, Alison J Carreira, Suzanne Riisnaes, Ruth Finneran, Laura Hall, Emma Ishikawa, Yuji Nakai, Kiyohiko Tunariu, Nina Basu, Bristi Kaiser, Martin Lopez, Juanita Suzanne Minchom, Anna de Bono, Johann S Banerji, Udai